Roles of RNA Methylation on Tumor Immunity and Clinical Implications

Area of Science:

• Molecular Biology
• Immunology
• Biochemistry

Background:

• RNA methylation is a prevalent post-transcriptional modification found in both eukaryotes and prokaryotes.
• This modification occurs on various RNA types, including messenger RNA (mRNA) and non-coding RNA (ncRNA).
• Key types of RNA methylation include N6-methyladenosine (m ⁶ A), 5-methylcytosine (m ⁵ C), 7-methylguanosine (m ⁷ G), and 2-O-methylation.

Purpose of the Study:

• To explore the diverse roles of RNA methylation in biological processes.
• To investigate the specific impact of RNA methylation on the immune system, particularly in the context of tumor immunity.
• To highlight the potential of RNA methylation as a therapeutic target for immunological disorders and cancer immunotherapy.

Main Methods:

• Literature review of existing studies on RNA methylation.
• Analysis of the molecular mechanisms by which RNA modifications influence RNA fate and function.
• Examination of the interplay between RNA methylation and immune cell maturation, response, and innate immunity.

Main Results:

• RNA methylation modifications significantly affect RNA splicing, nucleation, stability, and immunogenicity.
• These modifications play a critical role in regulating the maturation and functional responses of immune cells.
• RNA methylation influences innate immunity by modulating RNA immunogenicity and interacting with innate immune components.

Conclusions:

• RNA methylation is a vital regulatory mechanism with broad implications in physiology and pathology.
• Specifically, RNA methylation profoundly impacts tumor immunity, affecting immune cell function and innate immune responses.
• Targeting RNA methylation presents a promising avenue for developing novel treatments for immunological diseases and advancing cancer immunotherapy.